Main

Neonatal respiratory failure is a serious clinical problem (1–3) associated with high morbidity, mortality, and cost (4–6). The mainstay of management is supportive care with mechanical ventilation, and important adjunctive therapies include high-frequency ventilation, surfactant therapy, inhaled nitric oxide, and extracorporeal membrane oxygenation (ECMO). Many term and preterm infants die due to cardiorespiratory failure despite maximal ventilatory support (3–10). It is well known that ventilatory support by itself may inflict lung injury (11,12). Animal and human studies indicate that volutrauma contributes to the development of lung injury (13–15). ECMO, a treatment of last resort for term or near-term neonates with profound cardiopulmonary disease, allows the lung to rest and recover, attenuating the often damaging effects of aggressive mechanical ventilation. However, ECMO is currently reserved for newborn infants with reversible pulmonary disease in whom conventional or high-frequency ventilation with inhaled nitric oxide has failed. This is due to serious inherent risks of ECMO, such as coagulopathy and the need for systemic anticoagulation, which predisposes to systemic and intracranial hemorrhage. An essential element in the ECMO circuit is a mechanical pump that directly leads to shear stress-induced injury of blood cells (16). The evolution of membrane and oxygenator technology has led to low-resistance membrane gas exchange devices that permit significant flow even when the circuit is not driven by a pump. Several investigators have reported the ability of these devices to partially support adult patients in respiratory failure. Gattinoni et al. (17) proved the efficacy and safety of extracorporeal carbon dioxide removal in combination with low-frequency ventilation. Flörchinger et al. (18) reported their successful 10-y institutional experience of using pumpless extracorporeal lung assist devices (LAD) to support patients with deteriorating gas exchange for prolonged periods. In a prospective, randomized, unblinded study, the LAD decreased ventilator-induced lung injury (VILI) and improved 5-d survival in a severe acute respiratory distress syndrome(ARDS) model in adult sheep (19). We tested the hypothesis that the LAD would reduce lung damage in a model of acute lung injury in juvenile piglets.

MATERIALS AND METHODS

The Institutional Animal Care and Use Committee of the University of Alabama at Birmingham approved the research protocol. All animal care and handling was in accordance with the guidelines of the National Institutes of Health.

Surgery.

Three- to 4-wk-old piglets were endotracheally intubated and mechanically ventilated using an Infant Star ventilator (Infant Star 950, Nellcor Puritan Bennett, Pleasanton, CA) and maintained on general anesthesia using 1.5–5% isoflurane titrated to keep animals deeply sedated. Animals were placed on a table with a heating pad to maintain body temperature at 37–38°C. Five French catheters were inserted into the thoracic aorta via the right femoral artery for measurement of systemic arterial pressure and into the inferior vena cava via the right femoral vein for measurement of central venous pressure. After a left third to fourth interspace thoracotomy, a 10- or 12-mm ultrasonic flow transducer (T101, Transonic systems, Ithaca, NY) was affixed around the main pulmonary artery to measure cardiac output (20). The left carotid artery and internal jugular vein were surgically exposed and cannulated with low-resistance catheters (Medtronic, Minneapolis, MN) of 8F and 10F diameters, respectively. The LAD was primed with 60 mL of heparinized normal saline, debubbled of air, and attached to the vascular cannulae. Another ultrasonic flow transducer (HT110, Transonic systems, Ithaca, NY) was placed on the outflow tubing to measure blood flow through the LAD. Animals were anticoagulated with a bolus of 50 units/kg of heparin after cannulation and maintained on a heparin infusion at a rate of 100 units/h. After surgery, study animals were observed for 30 min to allow for stabilization (Fig. 1).

Figure 1
figure 1

Photograph showing blood flowing from the carotid artery into the LAD and then back to the jugular vein, while O2 flows in a counter-current manner through the LAD.

Experimental protocols.

Twenty-four juvenile piglets were assigned to four groups (n = 6 per group): 1) Controls (control group): piglets did not receive lung lavage but were acutely instrumented and ventilated at very low settings during the surgical procedure. Animals were killed at the end of surgery. 2) Saline lavage-alone [SLL group (saline lung lavage)]: piglets were acutely instrumented, ventilated at very low settings during the surgical procedure, and received lung lavage. Animals were killed immediately after lavage. 3) Lavage followed by IMV (IMV group): piglets were instrumented and received lung lavage followed by conventional intermittent mandatory ventilation (IMV). 4) Lavage followed by IMV, combined with LAD (LAD group): piglets were instrumented and received lung lavage followed by IMV and LAD support.

Acute lung injury was induced by repeated lung lavages at 5-min intervals using 0.9% warm saline (30 mL/kg). Lavages were continued until partial pressure of arterial oxygen (Pao2) values decreased to less than 60 torr at FiO2 1.0 and there was a minimum reduction of 30% in dynamic lung compliance. Postlavage, initial ventilatory settings were positive inspiratory pressure (PIP) = 12 cm H2O, positive end-expiratory pressure (PEEP) = 4 cm H2O, respiratory rate (RR) = 24 breaths/min, and FiO2 = 1.0. The PEEP was maintained at 4 cm H2O throughout the experiments. In both the IMV and LAD groups, PIP was adjusted by 20% increments to reach a tidal volume of 6 mL/kg. Once the targeted tidal volume was achieved, respiratory rate was reduced to attempt to maintain partial pressure of arterial carbon dioxide (Paco2) in the 45–55 torr range. Concurrently, FiO2 was reduced to keep Pao2 above 60 torr (Fig. 2). Sweep gas flow through the LAD (100% O2) was controlled by a flow meter and set at 1.5–2 times blood flow through the device. The goal pH was 7.20–7.35. The duration of the experiment was limited to 6 h.

Figure 2
figure 2

Algorithm for ventilator management of experimental groups. TV, Tidal volume.

Measurements.

Throughout the experiment, heart rate (physiologic recorders; Gould-Brush 2400S, Oxnard, CA), systemic arterial pressure, pulmonary arterial pressure (pressure transducers; Spectramed P23XL, Oxnard, CA), oxygen saturation by pulse oximetry (N-100 C, Nellcor, Pleasanton, CA), pulmonary artery flow, and blood flow through the LAD by flow transducers were continuously recorded. Lung compliance and tidal volume were measured and recorded using a Bicore pulmonary function apparatus (Bicore, Pulmonary Monitor CP-100, Irvine, CA), which used a pneumotachograph attached to the endotracheal tube adapter.

Blood samples.

Arterial as well as pre and postdevice blood gases were monitored at baseline, 30 min after lung injury, and 15 min after changes in ventilatory settings using a blood gas analyzer (ABL 700 series, Radiometer America Inc., Westlake, OH).

Histologic assessment.

After the animals were killed at the conclusion of the experiment with an overdose of pentobarbital, the trachea was clamped at end-expiration with a PEEP of 5 cm H2O, and the lungs were removed en bloc. Lungs were fixed in 10% formalin for 24 h, transferred to 70% alcohol, and paraffin-embedded. Five micrometer-thick lung sections were prepared from the cranial dorsal (nondependent) and caudal ventral (dependent) regions. Hematoxylin and eosin stained sections were scored using a semiquantitative scoring system by two independent observers blinded to the treatment group (21–24). Variables scored were alveolar and interstitial inflammation, alveolar and interstitial hemorrhage, edema, atelectasis, and necrosis. Severity of injury was graded by the following scale: no injury = 0; injury to 25% of the field = 1; injury to 50% of the field = 2; injury to 75% of the field = 3; and diffuse injury = 4. Ten random fields from each section were examined at 40× magnification to minimize the effect of regional variation. Injury scores were averaged for analysis.

Statistical analysis.

Data were expressed as mean ± SEM and were displayed and analyzed by SigmaStat v. 3.5 (Jandel Scientific, San Rafael, CA). Lung injury scores were considered as the primary outcome and were analyzed using ANOVA followed by Tukey's test.

Hemodynamic variables, arterial blood gases, and pH were compared over time by repeated measures ANOVA. If significant differences were found by repeated measures ANOVA, multiple comparisons by Dunnett's test (for hemodynamic variables) or Tukey's test (for blood gases) were performed. A p value of <0.05 was considered statistically significant.

RESULTS

One animal in each of the LAD and the IMV groups died shortly before the completion of the study. Data from these animals were included in analysis.

Hemodynamics.

Both the groups had similar baseline characteristics for body weight, hematocrit (Hct), heart rate (HR), mean arterial pressure (MAP), and cardiac output (CO). These variables remained statistically comparable among the groups at the end of the study. Cardiac output decreased in both the groups because of the natural course of the lung injury model (Fig. 3A and B). Blood flow through the LAD was constant and ranged from 14 to 32 mL/kg/min and averaged 26 mL/kg/min or 25% of cardiac output. Despite the arteriovenous shunt, the heart rate and MAP remained relatively constant and were not different from baseline.

Figure 3
figure 3

Changes in heart rate (A) and cardiac output (B) of the LAD group compared with the IMV group during 6-h postlung lavage. Pre, baseline values before lung lavage; 0.5 h, 30-min postlavage and after LAD connection to the animal. All the values are mean ± SEM (p > 0.05). Filled circles represent the LAD group and open circles represent the IMV group.

Lung function.

Baseline Pao2/FiO2 ratio and pulmonary compliance (Cdyn) were similar in both the groups. Saline lavage caused profound pulmonary dysfunction as evidenced by a significant and similar decrease in Pao2/FiO2 ratio and decrease in Cdyn in all the animals.

PIP needed to be increased to maintain Pao2 and Paco2 in the IMV group. The LAD allowed significant reduction in PIP, tidal volume (VT), and FiO2 compared with the settings after lavage (Table 1 and Fig. 4). Target VT could be achieved in LAD group compared with IMV group. Paco2 remained higher than our target of 45–55 torr in both the groups and hence ventilatory rate was not reduced. Both the LAD and IMV groups developed mild respiratory acidosis compared with the control and SLL group, and the IMV group also developed metabolic acidosis (Table 1).

Table 1 Changes of peak inspiratory pressure, pulmonary compliance, and arterial blood gases of LAD group compared with IMV group as postlavage and at the end of the study
Figure 4
figure 4

Changes in peak inspiratory pressure (A), tidal volume (B), and Pao2/FiO2 ratio (C) of the LAD group compared with the IMV group during 6 h. Pre, baseline values before lung lavage; 0.5 h, 30-min postlavage and after LAD connection to the animal. All the values are mean ± SEM (*p < 0.05). Filled circles represent the LAD group and open circles represent the IMV group.

Histology.

Lung lavage induced injury in the SLL group compared with the control group. Lungs of the IMV group demonstrated gross damage including edema with distinct emphysematous and hemorrhagic changes on the pleural surfaces. Lung injury scores were increased in the IMV group compared with the control, SLL, and LAD groups (Fig. 5; p < 0.05). Lungs from the IMV group demonstrated significantly thickened and congested alveolar walls, marked alveolar inflammation, and airway injury compared with the other three groups (Fig. 6). The LAD group had significantly less total lung injury scores, inflammatory response, and airway injury compared with the IMV group and was not statistically different compared with the control group (Figs. 5 and 6).

Figure 5
figure 5

Comparison of lung injury scores among all the four groups revealing the raw data as a vertical dot plot superimposed on the box plot of the median of the total lung injury score with the 5th and 95th percentile of six animals in each group. TLIS, total lung injury score; Control, Control group; SLL, lavage-alone group; IMV, lavage followed by mechanical ventilation group; LAD, LAD group. *p < 0.05 for IMV group compared with the other three groups.

Figure 6
figure 6

Photomicrographs of hematoxylin and eosin stained lung sections from Control piglets (A), piglets in lavage group receiving lung lavage only (B), piglets in IMV group receiving lung lavage and mechanical ventilation during 6 h (C), and piglets in LAD group receiving lung lavage, mechanical ventilation and supported by the LAD for 6 h (D).

DISCUSSION

To our knowledge, this is the first study to examine the effects of a pumpless extracorporeal LAD on lung histopathology in a juvenile animal model of acute lung injury. It was designed to evaluate the combined effect of the LAD and a lung-protective ventilation strategy in an animal model of induced surfactant deficiency. This strategy depended on using a smaller tidal volume of 6 mL/kg and alveolar maintenance of lung volume by sufficient levels of PEEP. We aimed at maintaining a fixed PEEP that was enough to maintain lung expansion while decreasing tidal volume to prevent overinflation. Previous studies have shown that PEEP reduced severity of VILI and reduced damage produced by repeated opening and closing of lung units in surfactant deficient lungs; however, PEEP might favor hyperinflation if tidal volume was not reduced (25–27). The LAD coupled with low-frequency mechanical ventilation allowed for significant reductions in peak inspiratory pressures and tidal volumes, which were associated with reduced acute lung injury while achieving adequate gas exchange.

Recent technological advances have led to a new generation of low-resistance pumpless extracorporeal lung assist (pECLA) devices. These devices were developed to limit blood interaction with extracorporeal foreign surfaces and consumption of blood components secondary to shear stress, which are seen in ECMO (28–32). The LAD, a pECLA device, has sufficient membrane surface area for partial gas exchange. The LAD was shown to improve gas exchange and survival in adult animal models (33,34), and our study demonstrates that the LAD shows also preliminary feasibility and efficacy in a juvenile animal model.

The lung histology after lavage revealed diffuse involvement with alveolar hemorrhage, septal thickening, formation of hyaline membranes, increase in numbers of inflammatory cells within the intracellular space, and airway denudation. These findings are consistent with those described in acute lung injury models (35,36). Compared with the LAD and control groups, the IMV group demonstrated marked denudation of the airway epithelium either focally or diffusely, and a significant increase in the number of alveolar inflammatory cells. These differences are probably attributable to the significantly higher peak inspiratory pressures and tidal volumes that were necessary in the IMV group to achieve adequate gas exchange. This is consistent with literature that indicates that mechanical ventilation in animal models with high PIP (37) and large tidal volumes (36) leads to acute lung injury and ultimately to respiratory failure. These findings were supported by the large clinical, randomized trial conducted by the National Institutes of Health/National Heart, Lung, and Blood Institute ARDS Clinical Network on Ventilator Management that revealed a 25% improvement in the outcome of patients managed with lower tidal volumes (38).

In our study, hemodynamic changes were similar in both the groups, with heart rate increasing and cardiac output and systemic arterial pressure decreasing during the course of the 6 h of the study. Mandava et al. (37) described systemic hypotension and decreased cardiac output in a similar RDS model. They attributed these changes to systemic capillary leak syndrome (SCLS) that manifests as intravascular volume depletion, hemoconcentration, and shock. They reported that SCLS developed as early as 2 h after starting IMV and evolved into a lethal form with cardiovascular collapse and death despite all supportive measures (37). Hypoxia was not the immediate cause of death. There was adequate response to epinephrine or to volume loading. These observations were very similar to ours. One animal died from each group of the study between the third and fourth hour after the induction of acute lung injury secondary to deterioration in cardiorespiratory status. This death rate was lower than the 50% rate described by Kaisers et al. (39) in juvenile pigs with lavage-induced respiratory distress syndrome.

The hemodynamic changes noted are unlikely to be secondary to the extracorporeal shunt, as they were comparable between the groups. Zwischenberger et al. (40) noted that despite a shunt of up to 25% of cardiac shunt through the LAD circuit for 7 d, there was no instability in the hemodynamic profile. Brunston et al. (41) showed that perfusion of vital organs was maintained within 80% of baseline in animals with an arteriovenous shunt of up to 25% of the cardiac output. In our study, the low-resistance LAD circuit allowed a blood flow of up to 32% of the cardiac output at a mean arterial blood pressure of around 70 mm Hg. Oxygen delivery and tissue perfusion were maintained as indicated by a normal oxygen saturation and lack of metabolic acidosis. Both arterial oxygen tension and mixed venous saturation were significantly higher in the LAD group than in the IMV group. The Pao2/FiO2 ratio, a reliable predictor of survival in ARDS (42), was higher in the LAD group at the end of the 6-h study. At the end of the experiment, the higher Paco2 than our target in both the LAD and IMV groups was probably related to the significant lung damage in addition to fluid retention in the airways caused by lavage. Allowing for permissive hypercapnia, we could achieve target VT of 6 mL/kg with less PIP, therefore reducing VILI.

One of the limitations of our study is that lung lavage does not accurately simulate RDS. However, the goal of this study was to test the effect of the LAD on VILI in a surfactant-deficient juvenile animal model, as many newborn pulmonary diseases are associated with surfactant deficiency being secondary to prematurity, pneumonia, or meconium aspiration. Repeated lavage with depletion of surfactant decreases lung compliance, impairs gas exchange, facilitates alveolar collapse, and increases the likelihood of mechanical injury to alveolar walls during repeated cycles of opening and closing during mechanical ventilation. Therefore, the surfactant-depletion model is useful for evaluation of VILI. Other animal models of ALI that have been reported in the literature include oleic acid, LPS, acid aspiration, hyperoxia, bleomycin, pulmonary ischemia-reperfusion, nonpulmonary ischemia reperfusion, i.v. bacteria, intrapulmonary bacteria, peritonitis, cecal ligation, and puncture. However, the advantage of the surfactant-depletion model is that it provides a useful way to test the effect of different ventilatory strategies on development of tissue injury because injury would result more from the ventilatory strategies than from the saline lavage. In contrast, the other methods such as acid aspiration lead to significant lung injury and the additional injury of larger tidal volumes may be harder to assess. The LAD is also dependent on cardiac output and hence cannot be expected to support gas exchange in cardiogenic shock or other conditions with poor cardiac output. Another limitation is that this study evaluated only the short-term effects of lung lavage and mechanical ventilation. Although it may not be optimal, this acute model of lung injury is supported by a good body of literature (43–49), and the promising short-term results demonstrate the feasibility for longer-term studies.

In conclusion, the LAD improved gas exchange and reduced VILI in juvenile piglets after lung lavage while maintaining normal hemodynamics. Future studies are required to improve the biocompatibility of the LAD, test long-term efficacy in chronically instrumented animals, and evaluate less invasive methods of using the LAD, such as connection to the umbilical vessels, which would increase the clinical relevance of the device.